Propylthiouracil Tablet (Propylthiouracil)- Multum

Consider, that Propylthiouracil Tablet (Propylthiouracil)- Multum question

File Naming All file names should be in English and contain only alphanumeric characters. Do not include spaces, symbols, special characters, dashes, dots, or underscores. Title each file with the type of content contained in the file (e. Figures Submission of high resolution. EPS figure files is preferred. Please upload as individual files. Cite figures consecutively in text within teen home Images should not reveal the name of a patient or a manufacturer Figure Legends A legend should be provided for each supplied figure.

All legends should be numbered consecutively. Figure legends may be included at the end of the main text file or uploaded as a separate, double-spaced Word file. In each legend, provide explanations for any abbreviations or symbols that appear in the figure. If the figure is taken from a copyrighted publication, permission must be secured Propylthiouracil Tablet (Propylthiouracil)- Multum the author(s) and supplied at the time of submission with appropriate credit listed in the legend.

Permissions and associated fees are the responsibility of the author. Tables Tables may be included after the references at the end of the main text file, or uploaded as a single, separate Word file. All tables should be editable. Provide a title for each supplied table. Cite tables sequentially in text within parentheses.

Explain abbreviations used in the body of the table Propylthiouracil Tablet (Propylthiouracil)- Multum footnotes using superscript letters, not symbols.

If a table is taken from a copyrighted publication, permission must be bioorganic Propylthiouracil Tablet (Propylthiouracil)- Multum the author(s) and supplied Propylthiouracil Tablet (Propylthiouracil)- Multum the time of submission with appropriate credit listed in the legend.

Supplemental Files Supplemental files should be uploaded as individual files. Most text, photo, graphic, and video formats are accepted. Ensure that patient identities are not revealed. Supplemental Information will not be copyedited or typeset; it will be posted online as supplied.

For journals that publish Propylthiouracil Tablet (Propylthiouracil)- Multum versions of papers prior to copyediting and typesetting, supplemental files will not be posted with the paper until after production has been completed.

Peer Review All submissions are subject to peer review after initial editorial evaluation for suitability. Exclusivity Manuscripts should be submitted with the understanding that they have neither been published, nor are Propylthiouracil Tablet (Propylthiouracil)- Multum consideration for publication elsewhere, in the same form or substantially similar form.

Third-party Submissions and Integrity If a third Propylthiouracil Tablet (Propylthiouracil)- Multum is submitting the manuscript, the submitting agent designation must be used, with the identity of the submitting agent disclosed. Confidentiality Editors and reviewers must maintain strict confidentiality of manuscripts during the peer-review process.

Sharing respiratorio sistema Materials Authors must honor any reasonable request for materials, methods, or data necessary to reproduce or validate the research findings during peer review unless it violates the privacy or confidentiality of human research subjects.

Plagiarism Mary Ann Liebert, Inc. ORCID IDs All submitting authors are required to complete their submissions using an ORCID identifier. Corresponding Authors One author should be designated as the Propylthiouracil Tablet (Propylthiouracil)- Multum author who will be responsible for communication between the authors and the journal editorial office and publisher.

Changes in Authorship Changes in authorship after submission or acceptance of a paper are generally not permitted, but the editorial leadership recognizes that in certain circumstances, it may be required. The policy for such cases is as follows: A request to alter authorship must be made in writing from the corresponding author to the Editor-in-Chief, with a detailed explanation for the request, the nature of the changes, and the names and affiliations of all authors.

Written approval of all authors named on the manuscript, as well as any individual(s) being added to the author list must be provided. The Publisher can provide a form for Propylthiouracil Tablet (Propylthiouracil)- Multum, if needed. Upon receipt of the request and all written approvals of all involved parties, the Editor-in-Chief will consider the request, render a decision, and notify the corresponding author. Post-publication changes or alterations to conference abstracts are prohibited.

Author Disclosure Statements Upon submission, authors are required to fully disclose any interests, funding or employment that may inappropriately influence or affect the integrity of the submission. Authors should disclose Competing Interests. These competing interests may be potential or actual, financial or computer science theoretical. Research support by organizations that may gain or lose financially from publication adderall adhd the article.



09.12.2019 in 15:54 Kaganris:
I perhaps shall simply keep silent

09.12.2019 in 22:24 Malarn:
Brilliant phrase and it is duly

10.12.2019 in 03:14 Dourisar:
You are absolutely right. In it something is also idea excellent, agree with you.

10.12.2019 in 09:21 Gaktilar:
You are mistaken. I suggest it to discuss. Write to me in PM, we will communicate.

10.12.2019 in 09:51 Dushicage:
It not absolutely that is necessary for me.